Rodi Pharmaceuticals has under development a pipeline of health products: Non-prescription therapeutic nutraceuticals and prescription drugs ranging from pre-clinical to late stage studies. The pipeline addresses female infertility, male infertility, allo- and auto-immune diseases and the products are in several stages of development.
Our initial pipeline of "nutraceuticals" addressing female infertility is expected to be launched by the end of the year whereas the rest of the products will be launched over the next few years.
Rodi Pharmaceuticals has specialized in Research & Development, by offering a range of innovative and safe formulations.
Rodi Pharmaceuticals' suppliers work in accordance with a HACCP system set to their own in-house, as provided for by D.L. 193/2007 (November 6, 2007), “Implementation of Directive 2004/41/EC concerning Food Safety Checks and Application of Community Regulations in the same field”. Thus it guarantees the hygiene and the safety of their productions by locating, analyzing and monitoring the “critical momentss” of every process. Since 2002 our suppliers have had the certification of compliance with the UNI EN ISO 9001:2008 International Standard for checks over Research & Development, Production, Procurement, Quality Control, Sales and Stores.